Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.550
+0.080 (5.44%)
Jun 18, 2025, 4:00 PM - Market closed
Anebulo Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$5.50
Upside
+254.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | +93.55% | May 15, 2025 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +416.13% | Nov 19, 2024 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +416.13% | Oct 1, 2024 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +416.13% | Oct 3, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +287.10% | Sep 25, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +287.10% | Sep 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +287.10% | Sep 18, 2023 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +416.13% | May 18, 2023 |
| Benchmark | Benchmark | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +416.13% | Feb 14, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +287.10% | Jul 27, 2022 |
| Benchmark | Benchmark | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +867.74% | May 25, 2021 |